International trade · 13/09/1994Updated: 10/18/2026 · 1 min read
Dynabac Patent Receives Interim Extension
Summary
The U.S. Patent and Trademark Office has granted a one-year extension to the term of U.S. Patent No. 4,048,306, which covers the human drug product Dynabac.
Original source language: Federal Register — Department of CommerceOpen original release →